Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) Gross margin
Waters Corporation's gross margin over the twelve months to 30 June 2026 was 50.9%, down 8.4 percentage points from fiscal 2025 (59.3%). Over the past ten years it has ranged from 57.4% (fiscal 2020) to 59.6% (fiscal 2023); the current reading is higher than 82% of that period. That is in line with the Diagnostics & Research industry median of 50.9% and below the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 59.3% | (0.15) |
| FY2024 | 59.4% | (0.14) |
| FY2023 | 59.6% | 1.57 |
| FY2022 | 58.0% | (0.49) |
| FY2021 | 58.5% | 1.05 |
| FY2020 | 57.4% | (0.56) |
| FY2019 | 58.0% | (0.98) |
| FY2018 | 59.0% | (0.01) |
| FY2017 | 59.0% | 0.12 |
| FY2016 | 58.9% | 0.13 |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 44.6% | (1.79) |
| Mar 2026 | 46.4% | (14.66) |
| Dec 2025 | 61.1% | 2.05 |
| Sep 2025 | 59.0% | 0.65 |
| 42 more quarters | Free account |
Against its own ten years
Low 57.4%
High 59.6%
Ten-year median
58.9%
Current reading's percentile
82
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. compare | 66.4% |
| NTRA Natera, Inc. compare | 65.2% |
| GH Guardant Health, Inc. compare | 65.0% |
| IDXX IDEXX Laboratories, Inc. compare | 62.5% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation | 50.9% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. compare | 33.0% |
| Diagnostics & Research industry median | 50.9% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement